320 related articles for article (PubMed ID: 21846466)
21. The suppressor of metastasis Nm23-H1 interacts with the Cdc42 Rho family member and the pleckstrin homology domain of oncoprotein Dbl-1 to suppress cell migration.
Murakami M; Meneses PI; Lan K; Robertson ES
Cancer Biol Ther; 2008 May; 7(5):677-88. PubMed ID: 18728402
[TBL] [Abstract][Full Text] [Related]
22. Co-downregulation of PTEN, KAI-1, and nm23-H1 tumor/metastasis suppressor proteins in non-small cell lung cancer.
Goncharuk VN; del-Rosario A; Kren L; Anwar S; Sheehan CE; Carlson JA; Ross JS
Ann Diagn Pathol; 2004 Feb; 8(1):6-16. PubMed ID: 15129904
[TBL] [Abstract][Full Text] [Related]
23. Nm23-H1 promotes adhesion of CAL 27 cells in vitro.
Bago R; Pavelić J; Maravić Vlahovicek G; Bosnar MH
Mol Carcinog; 2009 Sep; 48(9):779-89. PubMed ID: 19263457
[TBL] [Abstract][Full Text] [Related]
24. Altered gene and protein expression by Nm23-H1 in metastasis suppression.
Lee JH; Marshall JC; Steeg PS; Horak CE
Mol Cell Biochem; 2009 Sep; 329(1-2):141-8. PubMed ID: 19415462
[TBL] [Abstract][Full Text] [Related]
25. Targeting tumor metastasis by regulating Nm23 gene expression.
Prabhu VV; Siddikuzzaman ; Grace VM; Guruvayoorappan C
Asian Pac J Cancer Prev; 2012; 13(8):3539-48. PubMed ID: 23098432
[TBL] [Abstract][Full Text] [Related]
26. Mutations at the dimer interface and surface residues of Nm23-H1 metastasis suppressor affect its expression and function.
Li Y; Liu W; Saini V; Wong YH
Mol Cell Biochem; 2020 Nov; 474(1-2):95-112. PubMed ID: 32705629
[TBL] [Abstract][Full Text] [Related]
27. CTCF and EGR1 suppress breast cancer cell migration through transcriptional control of Nm23-H1.
Wong KM; Song J; Wong YH
Sci Rep; 2021 Jan; 11(1):491. PubMed ID: 33436746
[TBL] [Abstract][Full Text] [Related]
28. Implication of metastasis suppressor NM23-H1 in maintaining adherens junctions and limiting the invasive potential of human cancer cells.
Boissan M; De Wever O; Lizarraga F; Wendum D; Poincloux R; Chignard N; Desbois-Mouthon C; Dufour S; Nawrocki-Raby B; Birembaut P; Bracke M; Chavrier P; Gespach C; Lacombe ML
Cancer Res; 2010 Oct; 70(19):7710-22. PubMed ID: 20841469
[TBL] [Abstract][Full Text] [Related]
29. [Effect of nm23-H1 on reversing malignant phenotype on human lung cancer cell line L9981].
Che G; Zhou Q; Wang Y; Liu L; Qin Y; Sun Z; Sun Z; Chen X
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2005 Jun; 22(3):530-4. PubMed ID: 16013253
[TBL] [Abstract][Full Text] [Related]
30. Potential contributions of antimutator activity to the metastasis suppressor function of NM23-H1.
Kaetzel DM; McCorkle JR; Novak M; Yang M; Jarrett SG
Mol Cell Biochem; 2009 Sep; 329(1-2):161-5. PubMed ID: 19381784
[TBL] [Abstract][Full Text] [Related]
31. Protein-protein interactions: a mechanism regulating the anti-metastatic properties of Nm23-H1.
Marino N; Marshall JC; Steeg PS
Naunyn Schmiedebergs Arch Pharmacol; 2011 Oct; 384(4-5):351-62. PubMed ID: 21713383
[TBL] [Abstract][Full Text] [Related]
32. Elevated extracellular vesicular Nm23-H1 subdues the pro-migratory potential of breast cancer cell-derived extracellular vesicles.
Saini V; Do Y; Yam JWP; Wong YH
Cell Signal; 2024 Aug; 120():111203. PubMed ID: 38723736
[TBL] [Abstract][Full Text] [Related]
33. Regulators affecting the metastasis suppressor activity of Nm23-H1.
Kim HD; Youn B; Kim TS; Kim SH; Shin HS; Kim J
Mol Cell Biochem; 2009 Sep; 329(1-2):167-73. PubMed ID: 19377884
[TBL] [Abstract][Full Text] [Related]
34. Regulation of matrix metalloproteinase 9 expression by Epstein-Barr virus nuclear antigen 3C and the suppressor of metastasis Nm23-H1.
Kuppers DA; Lan K; Knight JS; Robertson ES
J Virol; 2005 Aug; 79(15):9714-24. PubMed ID: 16014933
[TBL] [Abstract][Full Text] [Related]
35. Nm23-H1 homologs suppress tumor cell motility and anchorage independent growth.
McDermott WG; Boissan M; Lacombe ML; Steeg PS; Horak CE
Clin Exp Metastasis; 2008; 25(2):131-8. PubMed ID: 18058029
[TBL] [Abstract][Full Text] [Related]
36. [Effects of tumor metastasis suppressor gene nm23-H1 on invasion and proliferation of cervical cancer cell lines].
Yang Y; Lu S; Li MF; Wang ZH
Ai Zheng; 2009 Jul; 28(7):702-7. PubMed ID: 19624895
[TBL] [Abstract][Full Text] [Related]
37. Down-regulation of N-acetylglucosaminyltransferase V by tumorigenesis- or metastasis-suppressor gene and its relation to metastatic potential of human hepatocarcinoma cells.
Guo HB; Liu F; Zhao JH; Chen HL
J Cell Biochem; 2000 Sep; 79(3):370-85. PubMed ID: 10972975
[TBL] [Abstract][Full Text] [Related]
38. Correlation of NM23-H1 cytoplasmic expression with metastatic stage in human prostate cancer tissue.
Andolfo I; De Martino D; Liguori L; Petrosino G; Troncone G; Tata N; Galasso A; Roma C; Chiancone F; Zarrilli S; Arrigoni G; Staibano S; Imbimbo C; Zollo M
Naunyn Schmiedebergs Arch Pharmacol; 2011 Oct; 384(4-5):489-98. PubMed ID: 21553004
[TBL] [Abstract][Full Text] [Related]
39. Nm23-H1 inhibits lung cancer bone-specific metastasis by upregulating miR-660-5p targeted SMARCA5.
Ai C; Ma G; Deng Y; Zheng Q; Gen Y; Li W; Li Y; Zu L; Zhou Q
Thorac Cancer; 2020 Mar; 11(3):640-650. PubMed ID: 32022430
[TBL] [Abstract][Full Text] [Related]
40. Nm23-H1 suppresses metastasis by inhibiting expression of the lysophosphatidic acid receptor EDG2.
Horak CE; Mendoza A; Vega-Valle E; Albaugh M; Graff-Cherry C; McDermott WG; Hua E; Merino MJ; Steinberg SM; Khanna C; Steeg PS
Cancer Res; 2007 Dec; 67(24):11751-9. PubMed ID: 18089805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]